Oakworth Capital’s GSK GSK Stock Holding History

Oakworth Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-325	Closed	-$15.9K	–	865
2025 Q4	$15.9K	Buy	+325	New	+$15.2K	﹤0.01%	599
2025 Q2	–	Sell	-237	Closed	-$9.18K	–	670
2025 Q1	$9.18K	Buy	+237	New	+$8.68K	﹤0.01%	521
2024 Q4	–	Sell	-80	Closed	-$3.27K	–	651
2024 Q3	$3.27K	Hold	80	–	–	﹤0.01%	592
2024 Q2	$3.08K	Hold	80	–	–	﹤0.01%	625
2024 Q1	$3.43K	Hold	80	–	–	﹤0.01%	582
2023 Q4	$2.96K	Hold	80	–	–	﹤0.01%	594
2023 Q3	$2.9K	Hold	80	–	–	﹤0.01%	537
2023 Q2	$2.85K	Hold	80	–	–	﹤0.01%	572
2023 Q1	$2.85K	Hold	80	–	–	﹤0.01%	529
2022 Q4	$2.81K	Buy	+80	New	+$2.67K	﹤0.01%	513
2022 Q3	–	Sell	-1,600	Closed	-$87K	–	565
2022 Q2	$87K	Hold	1,600	–	–	0.01%	248
2022 Q1	$87K	Hold	1,600	–	–	0.01%	251
2021 Q4	$88K	Sell	1,600 -129	-7%	-$6.71K	0.01%	278
2021 Q3	$83K	Hold	1,729	–	–	0.01%	267
2021 Q2	$86K	Sell	1,729 -160	-8%	-$7.69K	0.01%	261
2021 Q1	$84K	Buy	1,889 +1,680	+804%	+$76.3K	0.01%	260
2020 Q4	$10K	Sell	209 -664	-76%	-$30.5K	﹤0.01%	427
2020 Q3	$41K	Buy	873 +13	+2%	+$651	0.01%	303
2020 Q2	$44K	Buy	860 +147	+21%	+$7.54K	0.01%	289
2020 Q1	$34K	Hold	713	–	–	0.01%	280
2019 Q4	$41K	Hold	713	–	–	0.01%	307
2019 Q3	$38K	Sell	713 -2,641	-79%	-$136K	0.01%	318
2019 Q2	$168K	Hold	3,354	–	–	0.03%	189
2019 Q1	$175K	Hold	3,354	–	–	0.04%	184
2018 Q4	$160K	Hold	3,354	–	–	0.04%	179
2018 Q3	$169K	Hold	3,354	–	–	0.03%	176
2018 Q2	$169K	Hold	3,354	–	–	0.04%	172
2018 Q1	$168K	Sell	3,354 -1,053	-24%	-$49K	0.04%	163
2017 Q4	$193K	Hold	4,407	–	–	0.05%	162
2017 Q3	$222K	Hold	4,407	–	–	0.06%	146
2017 Q2	$237K	Hold	4,407	–	–	0.06%	137
2017 Q1	$232K	Hold	4,407	–	–	0.07%	141
2016 Q4	$208K	Sell	4,407 -129	-3%	-$6.37K	0.07%	147
2016 Q3	$244K	Sell	4,536 -698	-13%	-$38.3K	0.08%	120
2016 Q2	$277K	Buy	5,234 +174	+3%	+$9.17K	0.1%	109
2016 Q1	$257K	Buy	5,060 +3,562	+238%	+$177K	0.1%	108
2015 Q4	$76K	Buy	1,498 +80	+6%	+$4.08K	0.03%	167
2015 Q3	$68K	Hold	1,418	–	–	0.04%	129
2015 Q2	$77K	Hold	1,418	–	–	0.04%	132
2015 Q1	$82K	Sell	1,418 -28	-2%	-$1.6K	0.04%	158
2014 Q4	$77K	Hold	1,446	–	–	0.04%	154
2014 Q3	$89K	Hold	1,446	–	–	0.05%	110
2014 Q2	$97K	Buy	1,446 +400	+38%	+$27.1K	0.06%	111
2014 Q1	$70K	Buy	1,046 +514	+97%	+$34.7K	0.05%	117
2013 Q4	$35K	Buy	+532	New	+$34.5K	0.02%	152

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Oakworth Capital's GSK Position: Q1 2026 in Review

Oakworth Capital sold out of GSK (GSK) in Q1 2026, closing a stake of 325 shares — an estimated $15.9K sold.

Oakworth Capital first reported a position in GSK in Q4 2013 and held it in 45 quarters. The position peaked at $277K in Q2 2016. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Oakworth Capital reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Oakworth Capital sold 325 GSK shares in Q1 2026, an estimated $15.9K.
Oakworth Capital first reported a position in GSK in Q4 2013 and held it in 45 quarters.
Oakworth Capital's GSK position peaked at $277K in Q2 2016.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Oakworth Capital's 13F filing for Q1 2026, filed 24 Apr 2026.